A spinoff of 'The Office' follows a struggling Midwestern newspaper's efforts to adapt to the digital age, with a returning cast member and a new editor-in-chief tasked with reviving the publication.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Democratic Rep. Jasmine Crockett faces allegations of staff abuse and a focus on building an online influencer persona rather than legislative duties.
A spinoff of 'The Office' follows a struggling Midwestern newspaper's efforts to adapt to the digital age, with a returning cast member and a new editor-in-chief tasked with reviving the publication.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Democratic Rep. Jasmine Crockett faces allegations of staff abuse and a focus on building an online influencer persona rather than legislative duties.